Deferoxamine and hespan complex as a resuscitative adjuvant in emorrhagic shock rat model

Shock

Volumn 17, Issue 4, 2002, Pages 339-342

  Rana, M Waheed ^a   Shapiro, Marc J ^a   Ali, M Arif ^a   Chang, Yao Jan ^a   Taylor, William H ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

Hydroxyethyl starch; Hypovolemic shock; Immunoassay; Iron chelator; Lidocaine; Liver function; Resuscitation

Indexed keywords

DEETHYLLIDOCAINE; DEFEROXAMINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HETASTARCH; HYDROXYETHYL STARCH DEFEROXAMINE CONJUGATE; HYDROXYETHYL STARCH-DEFEROXAMINE CONJUGATE; IRON CHELATING AGENT; ISOTONIC SOLUTION; LIDOCAINE; RINGER'S LACTATE;

ANIMAL; ARTICLE; DRUG EFFECT; HEMORRHAGIC SHOCK; LIVER CIRCULATION; MALE; METHODOLOGY; PATHOPHYSIOLOGY; RAT; RESUSCITATION; SPRAGUE DAWLEY RAT;

ANIMALS; DEFEROXAMINE; HETASTARCH; IRON CHELATING AGENTS; ISOTONIC SOLUTIONS; LIDOCAINE; LIVER CIRCULATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 0036549012     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200204000-00018     Document Type: Article

References (36)

1. Abreo K, Moorthy V, Osborne M: Changing patterns and outcome of acute renal failure requiring hemodialysis. Arch Intern Med 146:1338-1344, 1986.
2. Christou NV, Meakins JL: Neutrophil function in surgical patients: two inhibitors of granulocyte chemotaxis associated with sepsis. J Surg Res 26:355-364, 1979.
3. Shevach EM: Macrophages and other accessory cells: fundamental immunology. In Paul WE (ed):. New York: Raven Press, 1984, pp 71-107.
4. Unanue ER, Allen PM: The bases for the immunoregulatory role of macrophages and other accessory cells. Science 236:551-557, 1987.
5. Van Dijk WC, Verbrugh HA, Rijswijk REN, Vos A, Verhoe J: Neutrophil function, serum opsonic activity and delayed hypersensitivity in surgical patients. Surgery 92:21-29, 1982.
6. Halliwell B, Gutteridge JM: Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246:501-514, 1986.
7. Cerra FB: Multiple organ failure syndrome. In Bihasi DJ, Cerra FB (eds): Multiple Organ Failure. Fullerton, CA: Society of Critical Care Medicine 1989, pp 1-24.
8. Chaudry IH, Stephan RN, Harkema JM, Dean RE: Immunological alterations following simple hemorrhage. In Faist E, Ninneman J, Green D (eds): Immune Consequences of Trauma, Shock and Sepsis. Berlin: Springer-Verlag, 1989, pp 363-374.
9. Baue AE: Multiple Organ Failure: Patient Care and Prevention. St. Louis: Mosby Year Book, 1990, pp 421-470.
10. Bauer M, Feucht K, Ziegenfft T, Marzi I. Attenuation of shock induced hepatic microcirculatory disturbance by the use of a starch-deferoxamine conjugate for resuscitation. Crit Care Med 23:316-322, 1995.
11. Cross JS, Gruber DP, Burchard KW, Singh AK, Moran JM, Gann DS: Hypertonic saline therapy following surgery: a prospective study. J Trauma 29:817-826, 1989.
12. Schmall LM, Muir WW, Robertson JT: Hemotological, serum electrolytes and blood gas effects of small volume hypertonic saline in experimentally induced hemorrhagic shock. Equine Vet J 22:278-283, 1990.
13. Groenweld ABJ, Vermeij CG, Thijs LG: Atrial and mixed venous blood acid-base balance during hypoperfusion with incremental positive end-expiratory pressure in pig. Anesth Analg 73:576-582, 1991.
14. Drugas GT, Paidas CN, Yahanda AM, Ferguson D, Clemens MG: Conjugated deferoxamine alternates hepatic microcircular injury following ischemia/ reperfusion. Circ Shock 34:278-283, 1991.
15. Bauer C, Walcher F, Holanda M, Mertzlufft F, Larsen R, Marzi I: Antioxidative resuscitation solution to prevent leukocyte adhesion in the liver after hemorrhagic shock. J Trauma 46:886-893, 1999.
16. Chandel B, Shapiro MJ, Kurtz M, Rana MW, Matthews M, Jellnick M, Baue AE: MEGX (monoethylglycinexylidide): A novel in vivo test to measure early hepatic dysfunction after hypovolemic shock. Shock 3:51-53, 1995.
17. Animal Welfare Act. Federal Register 56:6424-6505, 1991.
18. Chaudry IH, Zweig S, Baue AE: Failure of nicotinamide in treatment of hemorrhage. J Surg Res 21:27-32, 1976.
19. Baker CC, Oppenheimer L, Lewis FR, Trunkey DD: The epidemiology of trauma death. Am J Surg 140:144-150, 1980.
20. Trunkey DD: Trauma. Sci Am 249:28-35, 1983.
21. Shires GT: Principles of Trauma Care, 3rd ed. New York: McGraw Hill, 1985, pp 3-42.
22. Baue AE: Multiple, progressive or sequential system failure: a syndrome of 1970s. Arch Surg 110:779-781, 1975.
23. Baue AE, Chaudry IH: Prevention of multiple system failure. Surg Clin North Am 60:1167-1178, 1980.
24. Chaudry IH: Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 245:R117-R134, 1983.
25. Cerra FB: Hypermetabolism-organ failure syndrome: a metabolic response to injury. Crit Care Clin 5:289-302, 1989.
26. Martin R, Bickell W, Pepe P, Burch J, Mattox K: Prospective evaluation of preoperative fluid resuscitation in hypotensive patients with penetrating truncal injury: a preliminary report. J Trauma 33:354-361, 1992.
27. Schroeder TJ, Pesce AJ, Rychman F, Vine W, Balistreri W: Assessment of lidocaine metabolism. An indicator of liver function: a team transplant communication, MEGX monograph. Abbott Park, IL: Abbott Diagnostics, 1990, pp 1-35.
28. Van Warg G, Loof L, Groth T, Niklasson F: Alloparinol kinetics in human as a mean to assess liver function: evaluation of an alloparinol loading test. Scand J Clin Lab Invest 48:45-57, 1988.
29. Gibaldi M: Test drugs to evaluate hepatic clearance. Perspect Clin Pharmacol 6:1-3, 1988.
30. Wang P, Singh G, Rana MW, Ba ZF, Chaudry IH: Preheparinization improves F organ function after hemorrhage and resuscitation. Am J Physiol 259:R645-R650, 1990.
31. Makowa L, Gordon RD, Todo S: Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 19:2378-2382, 1987.
32. Oellerich M, Burdelski M, Lautz H, Rodeck B, Duvell J. Prognostic value of the MEGX liver function test in transplant candidates. Clin Chem 35:1135, 1989.
33. Littlefield M, Kolaczkowski L, Wang P, Schroeder TJ: Monoethylglycinexylidide determined by fluorescence polarization immunoassay as a liver function test. Clin Chem 34:1159, 1988.
34. Gremse D, Akader H, Schroeder T, Balistreri W: Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 12:565-569, 1990.
35. Purcell P, Branson R, Schroeder T, David K, Johnson D: Monoethylglycinexylidide production parallels changes in hepatic blood flow and oxygen delivery in lung injury managed with positive end-expiratory pressure. J Trauma 33: 482-486, 1992.
36. Schroeder TJ, Gremse DA, Mansour ME, Theuerling M: Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Transplant Proc 21:2299-2301, 1989.